您的位置: 首页 > 农业专利 > 详情页

PROTÉINES DE FUSION FGF21 À ACTION PROLONGÉE ET COMPOSITION PHARMACEUTIQUE LES COMPRENANT
专利权人:
Yuhan Corporation
发明人:
申请号:
EP16860300.9
公开号:
EP3368554A4
申请日:
2016.10.28
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention provides a fusion protein comprising an FGF21 mutant protein and an Fc region of an immunoglobulin. The fusion protein according to the present invention exhibits improved pharmacological efficacy, in vivo duration and protein stability, and a pharmaceutical composition comprising the fusion protein as an active ingredient may be effectively used as a therapeutic agent for diabetes, obesity, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充